Oneness Biotech Co., Ltd.

This study is testing whether a new injectable drug called FB825 can help control moderate-to-severe eczema (atopic dermatitis). About 90 adults with eczema that hasn't responded well to standard creams will receive either FB825 or a placebo injection over 12 weeks, followed by 1…

This study is testing an investigational drug called FB825 to see if it can help control moderate-to-severe allergic asthma in adults. About 100 participants will receive either the drug or a placebo via IV infusion over 24 weeks, while continuing their standard inhaler medicatio…

This study is testing a new drug called FB704A to see if it is safe and can help control severe asthma. About 20 adults with severe asthma will receive either the drug or a placebo through an IV infusion over 8 weeks. Researchers will measure lung function, asthma symptoms, and q…

This is a very early study to check the safety and side effects of a new drug called SNS851, which is being developed for metabolic diseases. It will be given to 52 healthy volunteers to see how their bodies react to it. The main goal is to find out what doses are safe and how th…